Digital PCR (dPCR) and Real-time PCR (qPCR) Market by Product (Instruments, Reagents, Software, Services), Application (Clinical, Oncology, Forensics), End-user (Hospitals, Diagnostic Labs, Academia, Pharma-Biotech, CRO) - Global Forecast to 2024

デジタルPCR(dPCR)およびリアルタイムPCR(qPCR)の世界市場予測(~2024年)

◆タイトル:Digital PCR (dPCR) and Real-time PCR (qPCR) Market by Product (Instruments, Reagents, Software, Services), Application (Clinical, Oncology, Forensics), End-user (Hospitals, Diagnostic Labs, Academia, Pharma-Biotech, CRO) - Global Forecast to 2024
◆商品コード:BT 3161
◆調査・発行会社:MarketsandMarkets
◆発行日:2019年5月25日
◆ページ数:120
◆レポート形式:PDF / 英語
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆産業分野:バイオテクノロジー
◆販売価格オプション(消費税別)
Single User(1名様閲覧)USD5,650 ⇒換算¥604,550見積依頼/購入/質問フォーム
Multi User (Five User)USD6,650 ⇒換算¥711,550見積依頼/購入/質問フォーム
Corporate License (全社内共有可)USD8,150 ⇒換算¥872,050見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※ご購入後、レポートに記載の英語表現や単語の意味に関しましては無料でお答えいたします。(但し、対応範囲は弊社で判断)
※弊社H&Iグローバルリサーチ株式会社はMarketsandMarketsの日本における正規販売代理店です。

【レポートの概要】

デジタルPCR(dPCR)およびリアルタイムPCR(qPCR)の世界市場は、2019年の41億米ドルから2024年には63億米ドルに達し、この期間中8.8%の年平均成長率で成長すると予測されています。世界中で感染症および遺伝性疾患の発生率が高まっているため、より優れた迅速な診断検査が求められています。これを背景に、dPCRおよびqPCR市場における研究開発の全体的なペースは加速し、同時に投資、資金、および助成金の形で強力な財政支援が受けられるようになりました。以上の理由から、予測期間中、dPCRおよびqPCR市場は成長すると考えられています。一方で、機器のコスト(特にdPCRのコスト)が高価であること、およびPCRの技術的な限界により、市場の成長はある程度制限されると予測されます。当調査レポートでは、デジタルPCR(dPCR)およびリアルタイムPCR(qPCR)の世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、産業動向、市場シェア分析、製品(機器、試薬、ソフトウェア、サービス)別分析、用途(臨床、腫瘍、化学捜査)別分析、エンドユーザー(病院、診断ラボ、学界、学術機関、CRO)別分析、デジタルPCR(dPCR)およびリアルタイムPCR(qPCR)の世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。

“The global dPCR and qPCR market is projected to grow at a CAGR of 8.8% during the forecast period.”The global dPCR and qPCR market is projected to reach USD 6.3 billion by 2024 from USD 4.1 billion in 2019, at a CAGR of 8.8% from 2019 to 2024. The rising incidence of infectious diseases and genetic disorders across the world has spurred the demand for better and faster diagnostic tests. This has also boosted the overall pace of R&D in the dPCR and qPCR market along with the availability of strong financial support in the form of investments, funds, and grants. These factors are driving the growth of dPCR and qPCR market during the forecast period. However, high instrument costs—especially that of dPCR—and the technical limitations of PCR are expected to limit market growth to a certain extent.

“The qPCR reagents segment is expected to account for the largest market share of the global qPCR products and services market in 2019.”
The qPCR reagents and consumables segment is expected to account for the largest share among qPCR products in 2019. The expansion of qPCR applications in the field of clinical diagnosis, forensics, and genomic research, along with the increased funding for life science research and the rising number of probe-based multiplex genetic analysis procedures, are responsible for the dominance of the qPCR reagents and consumables segment.

“Clinical applications to show the highest growth in the dPCR and qPCR applications market during the forecast period.”
The clinical applications segment will show the highest growth in the dPCR and qPCR applications market during the forecast period. The growth of this segment can be attributed to factors such as the growing usage of qPCR in disease diagnosis, rising incidence of infectious and genetic diseases, and growing public emphasis on early & effective disease diagnosis & treatment. Furthermore, the technological benefits (such as high flexibility, increased device sensitivity, better precision, and absolute quantification of the target molecule) offered by dPCR over traditional disease testing techniques and the growing adoption of dPCR among hospitals & diagnostic centers are other factors driving the growth of this segment in the forecast period.

“North America to account for the largest share of the global market in 2019.”
North America accounts for the largest share of the dPCR and qPCR market owing to the high incidence of chronic and genetic diseases, rising geriatric population, growing adoption of qPCR and dPCR techniques in research & academia, and significant public-private funding in the field of genome analysis. Further, the strong presence of major pharmaceutical and biotechnology companies in the US and ongoing initiatives by the Canadian government to support life science, genomic, and clinical research are other few factors influencing the demand of dPCR and qPCR products in this region

Breakdown of supply-side primary interviews:
• By Company Type: Tier 1 – 45%, Tier 2 – 34%, and Tier 3 – 21%
• By Designation: C-level 10%, Director-level 14%, and Others – 76%
• By Region: North America – 31%, Europe – 33%, APAC – 19%, and RoW – 17%

The major players in the market include Abbott Laboratories (US), Agilent Technologies, Inc. (US), Analytik Jena AG (Germany), Becton Dickinson and Company (US), bioMérieux S.A. (France), Bio-Rad Laboratories, Inc. (US), Danaher Corporation (US), Eppendorf AG (Germany), F. Hoffman-La Roche Ltd. (Switzerland), Fluidigm Corporation (US), Merck KGaA (Germany), Promega Corporation (US), QIAGEN N.V. (Germany), Takara Bio, Inc. (Japan), and Thermo Fisher Scientific, Inc. (US).

Research Coverage
This report studies the dPCR and qPCR market based on product and services, application, end user, and region. The report also studies factors such as drivers, restraints, opportunities, and challenges affecting market growth. It analyzes the opportunities and challenges in the market and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micromarkets with respect to their individual growth trends and forecasts the revenue of the market segments with respect to five main regions and the respective countries in these regions.

Key Benefits of Buying the Report
This report focuses on various levels of analysis—industry trends, market shares of top players, and company profiles, which together form basic views and analyze the competitive landscape, emerging segments of the market, and high-growth regions, as well as their drivers, restraints, challenges, and opportunities. The report will help both established firms as well as new entrants/smaller firms to gauge the pulse of the market and garner greater market shares.

【レポートの目次】

TABLE OF CONTENTS

1 INTRODUCTION 19
1.1 OBJECTIVES OF THE STUDY 19
1.2 MARKET DEFINITION 19
1.3 STUDY SCOPE 20
1.3.1 MARKETS COVERED 20
1.3.2 YEARS CONSIDERED FOR THE STUDY 21
1.4 CURRENCY USED FOR THE STUDY 21
1.5 MARKET STAKEHOLDERS 21
2 RESEARCH METHODOLOGY 22
2.1 RESEARCH DATA 22
2.1.1 SECONDARY DATA 23
2.1.1.1 Key data from secondary sources 24
2.1.2 PRIMARY DATA 25
2.1.2.1 Key data from primary sources 25
2.1.2.2 Breakdown of Primaries 26
2.2 MARKET ESTIMATION METHODOLOGY 26
2.2.1 REVENUE MAPPING-BASED MARKET ESTIMATION 27
2.2.2 USAGE-BASED MARKET ESTIMATION 28
2.2.3 PRIMARY RESEARCH VALIDATION 29
2.3 DATA TRIANGULATION 30
2.4 RESEARCH ASSUMPTIONS 31
2.5 RESEARCH LIMITATIONS 31
3 EXECUTIVE SUMMARY 32
4 PREMIUM INSIGHTS 39
4.1 GLOBAL DPCR AND QPCR MARKET OVERVIEW 39
4.2 QPCR AND DPCR MARKET, BY REGION, 2019 VS.2024 (USD MILLION) 40
4.3 GLOBAL QPCR AND DPCR MARKET SHARE, BY PRODUCT AND SERVICE (2019) 41
4.4 GLOBAL QPCR MARKET, BY APPLICATION, 2019 VS. 2024 (USD MILLION) 42
4.5 GEOGRAPHICAL SNAPSHOT OF DPCR AND QPCR MARKET 43
5 MARKET OVERVIEW 44
5.1 INTRODUCTION 44
5.2 MARKET DYNAMICS 44
5.2.1 KEY MARKET DRIVERS 45
5.2.1.1 Rising incidences of target infectious diseases and genetic disorders 45
5.2.1.2 Continuous technological advancements in PCR technologies 46
5.2.1.3 Increasing investments, funds, and grants 47
5.2.1.4 Increasing use of biomarker profiling for disease diagnostics 48
5.2.1.5 Successful completion of the human genome project 49
5.2.2 KEY MARKET RESTRAINTS 49
5.2.2.1 High device costs associated with dPCR 49
5.2.2.2 Technical limitations of qPCR and dPCR techniques 49
5.2.3 KEY MARKET OPPORTUNITIES 50
5.2.3.1 Growing market penetration in emerging countries 50
5.2.3.2 Shift from plant-derived to genome-based drug discovery 50
5.2.4 KEY MARKET CHALLENGES 51
5.2.4.1 Adoption and implementation of MIQE guidelines 51
5.2.5 KEY MARKET TRENDS 51
5.2.5.1 Development of compact, portable, and lab-on-chip PCR devices 51
5.2.5.2 Ongoing technological integration with the PCR process 52
6 DPCR AND QPCR MARKET, BY PRODUCT & SERVICE 53
6.1 INTRODUCTION 54
6.2 QPCR PRODUCTS & SERVICES 54
6.2.1 QPCR REAGENTS AND CONSUMABLES 56
6.2.1.1 Global qPCR reagents and consumables market, by application 57
6.2.1.2 Global qPCR reagents and consumables market, by end user 58
6.2.2 QPCR INSTRUMENTS 58
6.2.2.1 Global qPCR instruments market, by application 59
6.2.2.2 Global qPCR Instruments Market, by End User 60
6.2.3 QPCR SOFTWARE AND SERVICES 60
6.2.3.1 Global qPCR software and services market, by application 61
6.2.3.2 Global qPCR software and services market, by end user 62
6.3 DPCR PRODUCTS & SERVICES 62
6.3.1 DPCR INSTRUMENTS 64
6.3.1.1 Global dPCR instruments market, by application 66
6.3.1.2 Global dPCR instruments market, by end user 66
6.3.2 DPCR REAGENTS AND CONSUMABLES 67
6.3.2.1 Global dPCR reagents and consumables market, by application 68
6.3.2.2 Global dPCR reagents and consumables market, by end user 68
6.3.3 DPCR SOFTWARE AND SERVICES 69
6.3.3.1 Global dPCR software and services market, by application 70
6.3.3.2 Global dPCR software and services market, by end user 70
7 DPCR AND QPCR MARKET, BY APPLICATION 71
7.1 INTRODUCTION 72
7.2 QPCR APPLICATIONS 72
7.2.1 CLINICAL APPLICATIONS 72
7.2.1.1 Infectious disease testing 74
7.2.1.1.1 The wide availability of qPCR assays and kits for infectious disease testing is a key factor driving market growth 74
7.2.1.2 Oncology testing 75
7.2.1.2.1 Advent of alternative diagnostic technologies for oncology testing to the key restraining factor 75
7.2.1.3 Blood screening 76
7.2.1.3.1 The advantages offered by qPCR such as the elimination of post-amplification processing and easy process automation to drive the demand for qPCR products 76
7.2.1.4 Transplant diagnostics 77
7.2.1.4.1 Increasing commercialization of qPCR products for transplant diagnostic to drive the market growth 77
7.2.1.5 Other clinical applications 78
7.2.2 RESEARCH APPLICATIONS 79
7.2.2.1 Increase in genome-based research activity boosts the market growth 79
7.2.3 FORENSIC APPLICATIONS 80
7.2.3.1 Limited adoption of qPCR in underdeveloped and developing countries is expected to restrict the market growth 80
7.3 DPCR APPLICATIONS 81
7.3.1 CLINICAL APPLICATIONS 81
7.3.1.1 Infectious disease testing 83
7.3.1.1.1 Accuracy and precision of dPCR have made it a prominent tool in infectious disease testing 83
7.3.1.2 Oncology testing 84
7.3.1.2.1 dPCR plays a vital role in oncology testing and clinical studies 84
7.3.1.3 Blood screening 85
7.3.1.3.1 dPCR offers multiple advantages over traditional techniques for blood screening 85
7.3.1.4 Transplant diagnostics 86
7.3.1.4.1 Low market availability of dPCR products for transplant diagnostics to reflect in small share of this market segment 86
7.3.1.5 Other clinical applications 87
7.3.2 RESEARCH APPLICATIONS 88
7.3.2.1 Wide usage of dPCR in genetic research is the primary driver for market growth 88
7.3.3 FORENSIC APPLICATIONS 89
7.3.3.1 The need to reduce the time and cost of forensic processes is a key factor driving market growth 89

8 DPCR AND QPCR MARKET, BY END USER 90
8.1 INTRODUCTION 91
8.2 QPCR END USERS 91
8.2.1 HOSPITALS AND DIAGNOSTIC CENTERS 92
8.2.2 RESEARCH LABORATORIES AND ACADEMIC INSTITUTES 93
8.2.3 PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES 95
8.2.4 CLINICAL RESEARCH ORGANIZATIONS 96
8.2.5 FORENSIC LABORATORIES 97
8.3 DPCR END USERS 99
8.3.1 HOSPITALS AND DIAGNOSTIC CENTERS 100
8.3.2 RESEARCH LABORATORIES AND ACADEMIC INSTITUTES 100
8.3.3 PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES 102
8.3.4 CLINICAL RESEARCH ORGANIZATIONS 103
8.3.5 FORENSIC LABORATORIES 104
9 DPCR AND QPCR MARKET, BY REGION 105
9.1 INTRODUCTION 106
9.2 NORTH AMERICA 107
9.2.1 US 112
9.2.1.1 US to dominate the North American dPCR and qPCR market in 2019 112
9.2.2 CANADA 113
9.2.2.1 Government initiatives for supporting genomics research to drive market growth in Canada 113
9.3 EUROPE 114
9.3.1 GERMANY 119
9.3.1.1 Germany to dominate the European dPCR and qPCR market 119
9.3.2 UK 120
9.3.2.1 Growing focus on genomics research to support market growth in the UK 120
9.3.3 FRANCE 121
9.3.3.1 Initiatives for developing genomic medicine to support market growth in France 121
9.3.4 REST OF EUROPE 122
9.4 ASIA PACIFIC 123
9.4.1 JAPAN 128
9.4.1.1 Strong research and healthcare infrastructure to support market growth in Japan 128
9.4.2 CHINA 130
9.4.2.1 Healthcare infrastructure modernization to support market growth in China 130

9.4.3 INDIA 131
9.4.3.1 Presence of a large target patient population to support market growth in India 131
9.4.4 REST OF APAC 132
9.5 LATIN AMERICA 133
9.5.1 BRAZIL 137
9.5.1.1 Brazil dominated the LATAM market in 2018 137
9.5.2 MEXICO 139
9.5.2.1 Favorable trade agreements will support imports and improve the accessibility to dPCR and qPCR instruments in Mexico 139
9.5.3 REST OF LATIN AMERICA 140
9.6 MIDDLE EAST AND AFRICA 141
9.6.1 LOW PURCHASING POWER OF END USERS AND INFRASTRUCTURAL LIMITATIONS TO RESTRAIN MARKET GROWTH IN THE MEA 141
10 COMPETITIVE LANDSCAPE 145
10.1 OVERVIEW 145
10.2 GLOBAL MARKET SHARE ANALYSIS 146
10.2.1 GLOBAL QPCR MARKET SHARE ANALYSIS (2018) 146
10.2.2 GLOBAL DPCR MARKET SHARE ANALYSIS (2018) 147
10.3 COMPETITIVE SCENARIO 148
10.3.1 KEY PRODUCT LAUNCHES, ENHANCEMENTS, AND APPROVALS (2016–2019) 148
10.3.2 KEY PARTNERSHIPS AND COLLABORATIONS (2016–2019) 148
10.3.3 KEY ACQUISITIONS (2016–2019) 149
10.3.4 KEY EXPANSIONS (2016–2019) 150
10.4 COMPETITIVE LEADERSHIP MAPPING 151
10.4.1 COMPETITIVE LEADERSHIP MAPPING: MAJOR MARKET PLAYERS (2018) 151
10.4.1.1 Visionary leaders 151
10.4.1.2 Innovators 151
10.4.1.3 Dynamic Differentiators 151
10.4.1.4 Emerging Companies 152
10.4.2 COMPETITIVE LEADERSHIP MAPPING: EMERGING COMPANIES/SMES/START-UPS (2018) 153
10.4.2.1 Progressive Companies 153
10.4.2.2 Starting Blocks 153
10.4.2.3 Responsive Companies 153
10.4.2.4 Dynamic Companies 153
11 COMPANY PROFILES 155
11.1 ABBOTT LABORATORIES 155
11.1.1 BUSINESS OVERVIEW 155
11.1.2 PRODUCTS OFFERED 156
11.1.3 RECENT DEVELOPMENTS (2016-2019) 157
11.2 AGILENT TECHNOLOGIES, INC. 158
11.2.1 BUSINESS OVERVIEW 158
11.2.2 PRODUCTS AND SERVICES OFFERED 159
11.2.3 RECENT DEVELOPMENTS (2016-2019) 160
11.3 ANALYTIK JENA AG (A WHOLLY OWNED SUBSIDIARY OF ENDRESS+HAUSER AG) 162
11.3.1 BUSINESS OVERVIEW 162
11.3.2 PRODUCTS AND SERVICES OFFERED 163
11.3.3 RECENT DEVELOPMENTS (2016-2019) 163
11.4 BECTON DICKINSON AND COMPANY 165
11.4.1 BUSINESS OVERVIEW 165
11.4.2 PRODUCTS AND SERVICES OFFERED 166
11.4.3 RECENT DEVELOPMENTS (2016-2019) 166
11.5 BIOMÉRIEUX S.A. 167
11.5.1 BUSINESS OVERVIEW 167
11.5.2 PRODUCTS AND SERVICES OFFERED 168
11.5.3 RECENT DEVELOPMENTS (2016-2019) 169
11.6 BIO-RAD LABORATORIES, INC. 170
11.6.1 BUSINESS OVERVIEW 170
11.6.2 PRODUCTS AND SERVICES OFFERED 171
11.6.3 RECENT DEVELOPMENTS (2016-2019) 172
11.6.4 MNM VIEW 173
11.7 DANAHER CORPORATION 174
11.7.1 BUSINESS OVERVIEW 174
11.7.2 PRODUCTS OFFERED 175
11.7.3 RECENT DEVELOPMENTS (2016-2019) 176
11.8 EPPENDORF AG 177
11.8.1 BUSINESS OVERVIEW 177
11.8.2 PRODUCTS OFFERED 178
11.8.3 RECENT DEVELOPMENTS (2016-2019) 178
11.9 F. HOFFMAN-LA ROCHE LTD. 179
11.9.1 BUSINESS OVERVIEW 179
11.9.2 PRODUCTS AND SERVICES OFFERED 180
11.9.3 RECENT DEVELOPMENTS (2016-2019) 181
11.10 FLUIDIGM CORPORATION 182
11.10.1 BUSINESS OVERVIEW 182
11.10.2 PRODUCTS OFFERED 183
11.10.3 RECENT DEVELOPMENTS (2016-2019) 183
11.11 MERCK KGAA 184
11.11.1 BUSINESS OVERVIEW 184
11.11.2 PRODUCTS AND SERVICES OFFERED 185
11.11.3 RECENT DEVELOPMENTS (2016-2019) 186
11.12 PROMEGA CORPORATION 187
11.12.1 BUSINESS OVERVIEW 187
11.12.2 PRODUCTS AND SERVICES OFFERED 187
11.12.3 RECENT DEVELOPMENTS (2016-2019) 188
11.13 QIAGEN N.V. 189
11.13.1 BUSINESS OVERVIEW 189
11.13.2 PRODUCTS OFFERED 190
11.13.3 RECENT DEVELOPMENTS (2016-2019) 191
11.14 TAKARA BIO, INC. 193
11.14.1 BUSINESS OVERVIEW 193
11.14.2 PRODUCTS AND SERVICES OFFERED 194
11.14.3 RECENT DEVELOPMENTS (2016-2019) 195
11.15 THERMO FISHER SCIENTIFIC, INC. 196
11.15.1 BUSINESS OVERVIEW 196
11.15.2 PRODUCTS AND SERVICES OFFERED 197
11.15.3 RECENT DEVELOPMENTS (2016-2019) 200
11.15.4 MNM VIEW 201
12 APPENDIX 202
12.1 DISCUSSION GUIDE 202
12.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 206
12.3 AVAILABLE CUSTOMIZATIONS 208
12.4 RELATED REPORTS 208
12.5 AUTHOR DETAILS 210

LIST OF TABLES

TABLE 1 GLOBAL DPCR AND QPCR MARKET, BY TECHNOLOGY, 2017–2024 (USD MILLION) 54
TABLE 2 GLOBAL QPCR PRODUCTS & SERVICES MARKET, BY TYPE,
2017–2024 (USD MILLION) 55
TABLE 3 QPCR PRODUCTS & SERVICES MARKET, BY REGION, 2017–2024 (USD MILLION) 55
TABLE 4 QPCR REAGENTS AND CONSUMABLES MARKET, BY REGION,
2017–2024 (USD MILLION) 57
TABLE 5 GLOBAL QPCR REAGENTS AND CONSUMABLES MARKET, BY APPLICATION,
2017–2024 (USD MILLION) 57
TABLE 6 GLOBAL QPCR REAGENTS AND CONSUMABLES MARKET, BY END USER,
2017–2024 (USD MILLION) 58
TABLE 7 QPCR INSTRUMENTS MARKET, BY REGION, 2017–2024 (USD MILLION) 59
TABLE 8 GLOBAL QPCR INSTRUMENTS MARKET, BY APPLICATION,
2017–2024 (USD MILLION) 59
TABLE 9 GLOBAL QPCR INSTRUMENTS MARKET, BY END USER, 2017–2024 (USD MILLION) 60
TABLE 10 QPCR SOFTWARE AND SERVICES MARKET, BY REGION,
2017–2024 (USD MILLION) 61
TABLE 11 GLOBAL QPCR SOFTWARE AND SERVICES MARKET, BY APPLICATION,
2017–2024 (USD MILLION) 61
TABLE 12 GLOBAL QPCR SOFTWARE AND SERVICES MARKET, BY END USER,
2017–2024 (USD MILLION) 62
TABLE 13 GLOBAL DPCR PRODUCTS & SERVICES MARKET, BY TYPE,
2017–2024 (USD MILLION) 63
TABLE 14 DPCR PRODUCTS & SERVICES MARKET, BY REGION, 2017–2024 (USD MILLION) 63
TABLE 15 DPCR INSTRUMENTS MARKET, BY REGION, 2017–2024 (USD MILLION) 65
TABLE 16 GLOBAL DPCR INSTRUMENTS MARKET, BY APPLICATION,
2017–2024 (USD MILLION) 66
TABLE 17 GLOBAL DPCR INSTRUMENTS MARKET, BY END USER, 2017–2024 (USD MILLION) 66
TABLE 18 DPCR REAGENTS AND CONSUMABLES MARKET, BY REGION,
2017–2024 (USD MILLION) 67
TABLE 19 GLOBAL DPCR REAGENTS AND CONSUMABLES MARKET, BY APPLICATION,
2017–2024 (USD MILLION) 68
TABLE 20 GLOBAL DPCR REAGENTS AND CONSUMABLES MARKET, BY END USER,
2017–2024 (USD MILLION) 68
TABLE 21 DPCR SOFTWARE AND SERVICES MARKET, BY REGION,
2017–2024 (USD MILLION) 69
TABLE 22 GLOBAL DPCR SOFTWARE AND SERVICES MARKET, BY APPLICATION,
2017–2024 (USD MILLION) 70
TABLE 23 GLOBAL DPCR SOFTWARE AND SERVICES MARKET, BY END USER,
2017–2024 (USD MILLION) 70
TABLE 24 GLOBAL QPCR MARKET, BY APPLICATION, 2017–2024 (USD MILLION) 72
TABLE 25 GLOBAL QPCR CLINICAL APPLICATIONS MARKET, BY TYPE,
2017–2024 (USD MILLION) 73
TABLE 26 QPCR CLINICAL APPLICATIONS MARKET, BY REGION, 2017–2024 (USD MILLION) 73
TABLE 27 QPCR CLINICAL APPLICATIONS MARKET FOR INFECTIOUS DISEASE TESTING,
BY REGION, 2017–2024 (USD MILLION) 74
TABLE 28 QPCR CLINICAL APPLICATIONS MARKET FOR ONCOLOGY TESTING, BY REGION, 2017–2024 (USD MILLION) 75
TABLE 29 QPCR CLINICAL APPLICATIONS MARKET FOR BLOOD SCREENING, BY REGION, 2017–2024 (USD MILLION) 76
TABLE 30 QPCR CLINICAL APPLICATIONS MARKET FOR TRANSPLANT DIAGNOSTICS,
BY REGION, 2017–2024 (USD MILLION) 77
TABLE 31 QPCR MARKET FOR OTHER CLINICAL APPLICATIONS, BY REGION,
2017–2024 (USD MILLION) 78
TABLE 32 QPCR RESEARCH APPLICATIONS MARKET, BY REGION, 2017–2024 (USD MILLION) 79
TABLE 33 QPCR FORENSIC APPLICATIONS MARKET, BY REGION, 2017–2024 (USD MILLION) 80
TABLE 34 GLOBAL DPCR MARKET, BY APPLICATION, 2017–2024 (USD MILLION) 81
TABLE 35 GLOBAL DPCR CLINICAL APPLICATIONS MARKET, BY TYPE,
2017–2024 (USD MILLION) 82
TABLE 36 DPCR CLINICAL APPLICATIONS MARKET, BY REGION, 2017–2024 (USD MILLION) 82
TABLE 37 DPCR CLINICAL APPLICATIONS MARKET FOR INFECTIOUS DISEASE TESTING,
BY REGION, 2017–2024 (USD MILLION) 83
TABLE 38 DPCR CLINICAL APPLICATIONS MARKET FOR ONCOLOGY TESTING, BY REGION, 2017–2024 (USD MILLION) 84
TABLE 39 DPCR CLINICAL APPLICATIONS MARKET FOR BLOOD SCREENING, BY REGION, 2017–2024 (USD MILLION) 85
TABLE 40 DPCR CLINICAL APPLICATIONS MARKET FOR TRANSPLANT DIAGNOSTICS,
BY REGION, 2017–2024 (USD MILLION) 86
TABLE 41 DPCR MARKET FOR OTHER CLINICAL APPLICATIONS, BY REGION,
2017–2024 (USD MILLION) 87
TABLE 42 DPCR RESEARCH APPLICATIONS MARKET, BY REGION, 2017–2024 (USD MILLION) 88
TABLE 43 DPCR FORENSIC APPLICATIONS MARKET, BY REGION, 2017–2024 (USD MILLION) 89
TABLE 44 GLOBAL QPCR MARKET, BY END USER, 2017–2024 (USD MILLION) 91
TABLE 45 QPCR MARKET FOR HOSPITALS AND DIAGNOSTIC CENTERS, BY REGION,
2017–2024 (USD MILLION) 93
TABLE 46 QPCR MARKET FOR RESEARCH LABORATORIES AND ACADEMIC INSTITUTES,
BY REGION, 2017–2024 (USD MILLION) 94
TABLE 47 QPCR MARKET FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES,
BY REGION, 2017–2024 (USD MILLION) 95
TABLE 48 QPCR MARKET FOR CLINICAL RESEARCH ORGANIZATIONS, BY REGION,
2017–2024 (USD MILLION) 96
TABLE 49 QPCR MARKET FOR FORENSIC LABORATORIES, BY REGION,
2017–2024 (USD MILLION) 98
TABLE 50 GLOBAL DPCR MARKET, BY END USER, 2017–2024 (USD MILLION) 99
TABLE 51 DPCR MARKET FOR HOSPITALS AND DIAGNOSTIC CENTERS, BY REGION,
2017–2024 (USD MILLION) 100
TABLE 52 DPCR MARKET FOR RESEARCH LABORATORIES AND ACADEMIC INSTITUTES,
BY REGION, 2017–2024 (USD MILLION) 101
TABLE 53 DPCR MARKET FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES,
BY REGION, 2017–2024 (USD MILLION) 102
TABLE 54 DPCR MARKET FOR CLINICAL RESEARCH ORGANIZATIONS, BY REGION,
2017–2024 (USD MILLION) 103
TABLE 55 DPCR MARKET FOR FORENSIC LABORATORIES, BY REGION,
2017–2024 (USD MILLION) 104
TABLE 56 DPCR AND QPCR MARKET, BY REGION, 2017–2024 (USD MILLION) 106
TABLE 57 NORTH AMERICA: QPCR MARKET, BY COUNTRY, 2017–2024 (USD MILLION) 109
TABLE 58 NORTH AMERICA: DPCR MARKET, BY COUNTRY, 2017–2024 (USD MILLION) 109
TABLE 59 NORTH AMERICA: QPCR MARKET, BY PRODUCT & SERVICE,
2017–2024 (USD MILLION) 109
TABLE 60 NORTH AMERICA: DPCR MARKET, BY PRODUCT & SERVICE,
2017–2024 (USD MILLION) 110
TABLE 61 NORTH AMERICA: QPCR MARKET, BY APPLICATION, 2017–2024 (USD MILLION) 110
TABLE 62 NORTH AMERICA: DPCR MARKET, BY APPLICATION, 2017–2024 (USD MILLION) 110
TABLE 63 NORTH AMERICA: QPCR MARKET, BY END USER, 2017–2024 (USD MILLION) 111
TABLE 64 NORTH AMERICA: DPCR MARKET, BY END USER, 2017–2024 (USD MILLION) 111
TABLE 65 US: QPCR MARKET, BY PRODUCT & SERVICE, 2017–2024 (USD MILLION) 112
TABLE 66 US: DPCR MARKET, BY PRODUCT & SERVICE, 2017–2024 (USD MILLION) 112
TABLE 67 CANADA: QPCR MARKET, BY PRODUCT & SERVICE, 2017–2024 (USD MILLION) 113
TABLE 68 CANADA: DPCR MARKET, BY PRODUCT & SERVICE, 2017–2024 (USD MILLION) 114
TABLE 69 EUROPE: QPCR MARKET, BY COUNTRY, 2017–2024 (USD MILLION) 116
TABLE 70 EUROPE: DPCR MARKET, BY COUNTRY, 2017–2024 (USD MILLION) 116
TABLE 71 EUROPE: QPCR MARKET, BY PRODUCT & SERVICE, 2017–2024 (USD MILLION) 116
TABLE 72 EUROPE: DPCR MARKET, BY PRODUCT & SERVICE, 2017–2024 (USD MILLION) 117
TABLE 73 EUROPE: QPCR MARKET, BY APPLICATION, 2017–2024 (USD MILLION) 117
TABLE 74 EUROPE: DPCR MARKET, BY APPLICATION, 2017–2024 (USD MILLION) 117
TABLE 75 EUROPE: QPCR MARKET, BY END USER, 2017–2024 (USD MILLION) 118
TABLE 76 EUROPE: DPCR MARKET, BY END USER, 2017–2024 (USD MILLION) 118
TABLE 77 GERMANY: QPCR MARKET, BY PRODUCT & SERVICE, 2017–2024 (USD MILLION) 119
TABLE 78 GERMANY: DPCR MARKET, BY PRODUCT & SERVICE, 2017–2024 (USD MILLION) 119
TABLE 79 UK: QPCR MARKET, BY PRODUCT & SERVICE, 2017–2024 (USD MILLION) 120
TABLE 80 UK: DPCR MARKET, BY PRODUCT & SERVICE, 2017–2024 (USD MILLION) 121
TABLE 81 FRANCE: QPCR MARKET, BY PRODUCT & SERVICE, 2017–2024 (USD MILLION) 121
TABLE 82 FRANCE: DPCR MARKET, BY PRODUCT & SERVICE, 2017–2024 (USD MILLION) 122
TABLE 83 ROE: QPCR MARKET, BY PRODUCT & SERVICE, 2017–2024 (USD MILLION) 123
TABLE 84 ROE: DPCR MARKET, BY PRODUCT & SERVICE, 2017–2024 (USD MILLION) 123
TABLE 85 APAC: QPCR MARKET, BY COUNTRY, 2017–2024 (USD MILLION) 125
TABLE 86 APAC: DPCR MARKET, BY COUNTRY, 2017–2024 (USD MILLION) 125
TABLE 87 ASIA PACIFIC: QPCR MARKET, BY PRODUCT & SERVICE,
2017–2024 (USD MILLION) 126
TABLE 88 ASIA PACIFIC: DPCR MARKET, BY PRODUCT & SERVICE,
2017–2024 (USD MILLION) 126
TABLE 89 ASIA PACIFIC: QPCR MARKET, BY APPLICATION, 2017–2024 (USD MILLION) 126
TABLE 90 ASIA PACIFIC: DPCR MARKET, BY APPLICATION, 2017–2024 (USD MILLION) 127
TABLE 91 ASIA PACIFIC: QPCR MARKET, BY END USER, 2017–2024 (USD MILLION) 127
TABLE 92 ASIA PACIFIC: DPCR MARKET, BY END USER, 2017–2024 (USD MILLION) 128
TABLE 93 JAPAN: QPCR MARKET, BY PRODUCT & SERVICE, 2017–2024 (USD MILLION) 129
TABLE 94 JAPAN: DPCR MARKET, BY PRODUCT & SERVICE, 2017–2024 (USD MILLION) 129
TABLE 95 CHINA: QPCR MARKET, BY PRODUCT & SERVICE, 2017–2024 (USD MILLION) 130
TABLE 96 CHINA: DPCR MARKET, BY PRODUCT & SERVICE, 2017–2024 (USD MILLION) 130
TABLE 97 INDIA: QPCR MARKET, BY PRODUCT & SERVICE, 2017–2024 (USD MILLION) 131
TABLE 98 INDIA: DPCR MARKET, BY PRODUCT & SERVICE, 2017–2024 (USD MILLION) 132
TABLE 99 ROAPAC: QPCR MARKET, BY PRODUCT & SERVICE, 2017–2024 (USD MILLION) 132
TABLE 100 ROAPAC: DPCR MARKET, BY PRODUCT & SERVICE, 2017–2024 (USD MILLION) 133
TABLE 101 LATIN AMERICA: QPCR MARKET, BY COUNTRY, 2017–2024 (USD MILLION) 135
TABLE 102 LATIN AMERICA: DPCR MARKET, BY COUNTRY, 2017–2024 (USD MILLION) 135
TABLE 103 LATIN AMERICA: QPCR MARKET, BY PRODUCT & SERVICE,
2017–2024 (USD MILLION) 135
TABLE 104 LATIN AMERICA: DPCR MARKET, BY PRODUCT & SERVICE,
2017–2024 (USD MILLION) 136
TABLE 105 LATIN AMERICA: QPCR MARKET, BY APPLICATION, 2017–2024 (USD MILLION) 136
TABLE 106 LATIN AMERICA: DPCR MARKET, BY APPLICATION, 2017–2024 (USD MILLION) 136
TABLE 107 LATIN AMERICA: QPCR MARKET, BY END USER, 2017–2024 (USD MILLION) 137
TABLE 108 LATIN AMERICA: DPCR MARKET, BY END USER, 2017–2024 (USD MILLION) 137
TABLE 109 BRAZIL: QPCR MARKET, BY PRODUCT & SERVICE, 2017–2024 (USD MILLION) 138
TABLE 110 BRAZIL: DPCR MARKET, BY PRODUCT & SERVICE, 2017–2024 (USD MILLION) 139
TABLE 111 MEXICO: QPCR MARKET, BY PRODUCT & SERVICE, 2017–2024 (USD MILLION) 139
TABLE 112 MEXICO: DPCR MARKET, BY PRODUCT & SERVICE, 2017–2024 (USD MILLION) 140
TABLE 113 ROLATAM: QPCR MARKET, BY PRODUCT & SERVICE, 2017–2024 (USD MILLION) 140
TABLE 114 ROLATAM: DPCR MARKET, BY PRODUCT & SERVICE, 2017–2024 (USD MILLION) 141
TABLE 115 MIDDLE EAST AND AFRICA: QPCR MARKET, BY PRODUCT & SERVICE,
2017–2024 (USD MILLION) 142
TABLE 116 MIDDLE EAST AND AFRICA: DPCR MARKET, BY PRODUCT & SERVICE,
2017–2024 (USD MILLION) 142
TABLE 117 MIDDLE EAST AND AFRICA: QPCR MARKET, BY APPLICATION,
2017–2024 (USD MILLION) 142
TABLE 118 MIDDLE EAST AND AFRICA: DPCR MARKET, BY APPLICATION,
2017–2024 (USD MILLION) 143
TABLE 119 MIDDLE EAST AND AFRICA: QPCR MARKET, BY END USER,
2017–2024 (USD MILLION) 143
TABLE 120 MIDDLE EAST AND AFRICA: DPCR MARKET, BY END USER,
2017–2024 (USD MILLION) 144


LIST OF FIGURES

FIGURE 1 RESEARCH DESIGN 22
FIGURE 2 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING 27
FIGURE 3 MARKET SIZE ESTIMATION METHODOLOGY: GLOBAL DPCR AND QPCR MARKET 28
FIGURE 4 DATA TRIANGULATION 30
FIGURE 5 GLOBAL QPCR PRODUCTS & SERVICES MARKET, BY TYPE, 2019 VS. 2024 33
FIGURE 6 GLOBAL DPCR PRODUCTS & SERVICES MARKET, BY TYPE, 2019 VS. 2024 34
FIGURE 7 GLOBAL QPCR MARKET, BY APPLICATION, 2019 VS. 2024 35
FIGURE 8 GLOBAL DPCR MARKET, BY APPLICATION, 2019 VS. 2024 36
FIGURE 9 APAC IS EXPECTED TO GROW AT THE HIGHEST RATE DURING
THE FORECAST PERIOD 37
FIGURE 10 RISING INCIDENCES OF TARGET INFECTIOUS DISEASES AND GENETIC DISORDERS IS EXPECTED TO DRIVE MARKET GROWTH 39
FIGURE 11 NORTH AMERICA IS EXPECTED TO DOMINATE BOTH QPCR AND DPCR MARKETS DURING THE FORECAST PERIOD 40
FIGURE 12 REAGENTS AND CONSUMABLES TO HOLD THE LARGEST SHARE IN THE GLOBAL DPCR AND QPCR MARKETS IN 2019 41
FIGURE 13 INFECTIOUS DISEASE TESTING TO BE THE FASTEST GROWING APPLICATION IN QPCR MARKET DURING FORECAST PERIOD 42
FIGURE 14 ASIA PACIFIC TO WITNESS HIGHEST GROWTH DURING THE FORECAST PERIOD 43
FIGURE 15 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 44
FIGURE 16 GLOBAL BURDEN OF HIV INFECTIONS, BY REGION, 2017 45
FIGURE 17 GROWING GERIATRIC POPULATION ACROSS KEY GEOGRAPHIES (2017 VS. 2030) 46
FIGURE 18 TRADITIONAL PCR VS. QPCR AND DPCR: A COMPARATIVE STUDY 47
FIGURE 19 REAGENTS AND CONSUMABLES SEGMENT TO DOMINATE THE QPCR PRODUCTS & SERVICES MARKET DURING THE FORECAST PERIOD 56
FIGURE 20 INSTRUMENTS SEGMENT TO WITNESS THE HIGHEST GROWTH IN THE DPCR PRODUCTS & SERVICES MARKET DURING THE FORECAST PERIOD 64
FIGURE 21 NORTH AMERICA: DPCR AND QPCR MARKET SNAPSHOT 108
FIGURE 22 EUROPE: DPCR AND QPCR MARKET SNAPSHOT 115
FIGURE 23 ASIA PACIFIC: DPCR AND QPCR MARKET SNAPSHOT 124
FIGURE 24 LATIN AMERICA: DPCR AND QPCR MARKET SNAPSHOT 134
FIGURE 25 KEY DEVELOPMENTS BY LEADING MARKET PLAYERS IN THE DPCR AND
QPCR MARKET, 2016–2019 145
FIGURE 26 GLOBAL QPCR MARKET SHARE ANALYSIS, BY KEY PLAYER (2018) 146
FIGURE 27 GLOBAL DPCR MARKET SHARE ANALYSIS, BY KEY PLAYER (2016) 147
FIGURE 28 GLOBAL COMPETITIVE LEADERSHIP MAPPING (OVERALL MARKET) 152
FIGURE 29 COMPETITIVE LEADERSHIP MAPPING (SME/START-UPS) 154
FIGURE 30 ABBOTT LABORATORIES: COMPANY SNAPSHOT (2018) 155
FIGURE 31 AGILENT TECHNOLOGIES, INC.: COMPANY SNAPSHOT (2018) 158
FIGURE 32 ENDRESS+HAUSER AG: COMPANY SNAPSHOT (2017) 162
FIGURE 33 BECTON DICKINSON AND COMPANY: COMPANY SNAPSHOT (2018) 165
FIGURE 34 BIOMÉRIEUX S.A.: COMPANY SNAPSHOT (2018) 167
FIGURE 35 BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT (2018) 170
FIGURE 36 DANAHER CORPORATION: COMPANY SNAPSHOT (2018) 174
FIGURE 37 EPPENDORF AG: COMPANY SNAPSHOT (2017) 177
FIGURE 38 ROCHE DIAGNOSTIC DIVISION: COMPANY SNAPSHOT (2018) 179
FIGURE 39 FLUIDIGM CORPORATION: COMPANY SNAPSHOT (2018) 182
FIGURE 40 MERCK KGAA: COMPANY SNAPSHOT (2018) 184
FIGURE 41 QIAGEN N.V.: COMPANY SNAPSHOT (2018) 189
FIGURE 42 TAKARA BIO, INC.: COMPANY SNAPSHOT (2018) 193
FIGURE 43 THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT (2018) 196


★調査レポート[デジタルPCR(dPCR)およびリアルタイムPCR(qPCR)の世界市場予測(~2024年)] ( Digital PCR (dPCR) and Real-time PCR (qPCR) Market by Product (Instruments, Reagents, Software, Services), Application (Clinical, Oncology, Forensics), End-user (Hospitals, Diagnostic Labs, Academia, Pharma-Biotech, CRO) - Global Forecast to 2024 / BT 3161) 販売に関する免責事項
[デジタルPCR(dPCR)およびリアルタイムPCR(qPCR)の世界市場予測(~2024年)] ( Digital PCR (dPCR) and Real-time PCR (qPCR) Market by Product (Instruments, Reagents, Software, Services), Application (Clinical, Oncology, Forensics), End-user (Hospitals, Diagnostic Labs, Academia, Pharma-Biotech, CRO) - Global Forecast to 2024 / BT 3161) についてEメールでお問い合わせ


◆H&Iグローバルリサーチ株式会社のお客様(例)◆